200
Participants
Start Date
March 10, 2025
Primary Completion Date
July 31, 2026
Study Completion Date
February 28, 2027
Combination Nicotine Replacement Therapy (patch and lozenge)
All participants receive 8 weeks of combination nicotine replacement therapy - long-acting transdermal patch and short-acting lozenge.
RECRUITING
University at Buffalo, Buffalo
RECRUITING
University of Pennsylvania, Philadelphia
Medical University of South Carolina
OTHER
University of Pennsylvania
OTHER
University of Alabama at Birmingham
OTHER
National Center for Advancing Translational Sciences (NCATS)
NIH
Abramson Cancer Center at Penn Medicine
OTHER
State University of New York at Buffalo
OTHER